2Seventy Bio Inc (TSVT) Stock
TSVT is no longer traded. 2Seventy Bio was delisted from the Nasdaq in May 2025.
Prices on this page are historical; the last trade was May 12, 2025 at $5.00.
2Seventy Bio stock price history
TSVT final trading statistics
- Final close
- $5.00
- Final trading day
- May 12, 2025
- Market cap at delisting
- $266.14M
- Shares outstanding
- 53.23M
- Final 52-week range
- $2.29 – $5.30
- Avg. volume (final 3 mo.)
- 1,364,624
- All-time high (split-adj.)
- $42.56 · Nov 2021
- All-time low (split-adj.)
- $1.57 · Nov 2023
- Return since IPO
- -63.7%
- Beta
- 1.05
- Book value / share
- $4.08
- Price / book
- 1.23
2Seventy Bio annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2024 | $37.86M | -$57.2M | -$1.06 |
| FY2023 | $100.39M | -$217.6M | -$4.02 |
| FY2022 | $91.50M | -$254.1M | -$7.58 |
| FY2021 | $54.52M | -$292.2M | -$12.77 |
| FY2020 | $248.12M | -$138.2M | -$3.68 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About 2Seventy Bio Inc
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. 2seventy bio, Inc. was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
2Seventy Bio stock FAQ
What happened to 2Seventy Bio stock?
2Seventy Bio stock was delisted from the Nasdaq. Its final close was $5.00 on May 12, 2025.
Is TSVT stock still trading?
No. TSVT was delisted from the Nasdaq in May 2025 and no longer trades on a U.S. exchange.
What was the last price of TSVT stock?
TSVT closed at $5.00 on its final trading day, May 12, 2025, for a market value of about $266.14M.
What were 2Seventy Bio's revenue and earnings in its last full fiscal year?
2Seventy Bio reported revenue of $37.86M and net income of -$57.2M in fiscal 2024, its last full year as a public company.
When did 2Seventy Bio go public?
2Seventy Bio Inc stock began trading on November 3, 2021.